Thompson Siegel & Walmsley LLC Eli Lilly & CO Transaction History

Thompson Siegel & Walmsley LLC

$6.24 Billion
Q2 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 2,146 shares of LLY stock, worth $1.95 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,146

Previous 3,445 37.71%

Holding current value

$1.95 Million

Previous $2.68 Million 27.5%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $941,606 - $1.18 Million	-1,299 Reduced 37.71%	2,146 $1.94 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $235,695 - $315,327	-398 Reduced 10.36%	3,445 $2.68 Million
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $598,191 - $705,189	1,139 Added 42.12%	3,843 $2.24 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $21,300 - $29,365	49 Added 1.85%	2,704 $1.45 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $71,550 - $95,671	-204 Reduced 7.14%	2,655 $1.25 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $229,244 - $269,237	-738 Reduced 20.52%	2,859 $982,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $1.16 Million - $1.35 Million	3,597 New	3,597 $1.32 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $487,220 - $572,067	-1,748 Reduced 32.7%	3,597 $1.17 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $24,642 - $30,624	-105 Reduced 1.93%	5,345 $1.53 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $3,779 - $4,892	23 Added 0.42%	5,450 $1.02 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $24,135 - $31,936	-185 Reduced 3.3%	5,427 $916,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $76,765 - $88,793	-525 Reduced 8.55%	5,612 $831,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $107,089 - $128,881	785 Added 14.67%	6,137 $1.01 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $45,761 - $56,680	428 Added 8.69%	5,352 $703,000
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $69,465 - $81,083	627 Added 14.59%	4,924 $546,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $44,524 - $52,408	400 Added 10.26%	4,297 $558,000
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $11,809 - $13,553	156 Added 4.17%	3,897 $333,000
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $2,374 - $2,803	-32 Reduced 0.85%	3,741 $289,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $37,938 - $40,693	-463 Reduced 10.93%	3,773 $319,000
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $77,070 - $85,540	1,000 Added 30.9%	4,236 $362,000
Q2 2017 Aug 09, 2017	BUY	N/A	3,236	3,236 $266,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Eli Lilly & CO Transaction History